TLE1: A Potential Drug Target and Transcriptional Corepressor

Target Name: TLE1

NCBI ID: G7088

TLE1

TLE1: A Potential Drug Target and Transcriptional Corepressor

Abstract:

TLE1 (TLE family member 1), also known as Transthyretin E1, is a protein that localizes to the endoplasmic reticulum (ER) and is involved in various cellular processes, including cell signaling, DNA replication, and stress responses. The TLE1 gene has been associated with various diseases, including heart failure, hypertension, and liver dysfunction. This article discusses the potential drug targeting of TLE1 and its implications for human health.

Introduction:

TLE1 (TLE family member 1) is a member of the TLE gene family, which is characterized by the presence of a variable region and a constant region. The TLE1 gene is expressed in various tissues and organs, including liver, heart, kidneys, and pancreas. TLE1 has been implicated in various cellular processes, including cell signaling, DNA replication, and stress responses.

Disease association:

TLE1 is associated with various diseases, including heart failure, hypertension, and liver dysfunction. Studies have shown that TLE1 levels are elevated in individuals with heart failure, and that downregulation of TLE1 has been observed in individuals with heart failure. Similarly, TLE1 has been associated with hypertension and liver dysfunction in various diseases, including heart failure, diabetes, and cancer.

Potential drug targeting:

The potential drug targeting of TLE1 comes from its involvement in various cellular processes that can be modulated by drugs. For instance, TLE1 has been shown to play a role in cell signaling, which can be modulated by anti-inflammatory drugs. Additionally, TLE1 has been linked to DNA replication, which can be affected by anti-cancer drugs. Furthermore, TLE1 is involved in stress responses, which can be modulated by drugs targeting stress responses, such as those used to treat anxiety disorders.

Analysis of TLE1 function:

TLE1 functions as a transcriptional corepressor, which means that it can bind to specific transcription factors and prevent them from activating target genes. This process is known as repression, and it can be modulated by various factors, including drug treatments. Repression of target genes by TLE1 can be either positive or negative, depending on the context.

In positive context, TLE1 can repress target genes that are involved in stress responses, cell signaling, and DNA replication. This can result in the downregulation of target genes, which can have a beneficial effect on cellular processes. For instance, TLE1 has been shown to repress the expression of genes involved in stress responses, such as those involved in the production of reactive oxygen species (ROS).

In negative context, TLE1 can also enhance the activity of target genes involved in stress responses, cell signaling, and DNA replication. This can have a detrimental effect on cellular processes, especially in diseases where stress responses are unwanted or excessive.

Conclusion:

TLE1 is a protein that is involved in various cellular processes, including cell signaling, DNA replication, and stress responses. Its function as a transcriptional corepressor makes it a potential drug target in various diseases. The potential drug targeting of TLE1 comes from its involvement in various cellular processes that can be modulated by drugs. Further research is needed to fully understand the role of TLE1 in disease and to develop effective drug treatments.

Protein Name: TLE Family Member 1, Transcriptional Corepressor

Functions: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. Enhances FOXG1/BF-1- and HES1-mediated transcriptional repression (By similarity). The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG

The "TLE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TLE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets